Cannabis use disorder is a clinical diagnosis describing a pattern of cannabis use that causes significant problems in a person’s life, from failed attempts to cut back to strained relationships and declining health. It requires meeting at least 2 of 11 specific criteria within a 12-month period. In 2023, roughly 19.2 million people in the United States, about 30% of those who reported using cannabis, met the criteria.
How It’s Diagnosed
The diagnosis is based on 11 criteria. You don’t need to meet all of them. Two or more within the past year is enough for a diagnosis, and the number you meet determines severity: mild (2 to 3), moderate (4 to 5), or severe (6 or more). The criteria cover three broad areas: loss of control over use, negative consequences from use, and physical dependence.
The 11 criteria are:
- Using more cannabis, or using it for longer, than you intended
- Wanting to cut down or stop but being unable to
- Spending a large amount of time getting, using, or recovering from cannabis
- Craving cannabis
- Failing to meet responsibilities at work, school, or home because of use
- Continuing to use despite it causing problems in relationships
- Giving up or reducing social, work, or recreational activities because of use
- Using cannabis in physically dangerous situations (such as driving)
- Continuing to use despite knowing it’s worsening a physical or mental health problem
- Needing more cannabis to get the same effect (tolerance)
- Experiencing withdrawal symptoms when stopping
The key distinction between regular use and a disorder is impairment. Someone who uses cannabis frequently but experiences none of these problems would not meet the criteria. The diagnosis hinges on whether use is creating real, measurable disruptions.
Who Is Most at Risk
Young adults are disproportionately affected. Among people aged 18 to 25, 16.6% met criteria for cannabis use disorder in 2023, roughly double the rate in the general population aged 12 and older (6.8%). Starting cannabis use earlier in life is one of the strongest predictors of developing problems later.
Genetics play a role too. Variations in genes involved in dopamine signaling appear to increase vulnerability. Research on twins illustrates this clearly: in pairs of identical twins where one twin had cannabis use disorder and the other didn’t, the affected twin was far more likely to also have depression (46% versus 28%). Family environment matters as well. Childhood maltreatment, family instability, and high levels of early-life stress all increase the likelihood of developing the disorder.
Higher-potency cannabis products also raise risk. A systematic review in The Lancet Psychiatry found that using higher-potency cannabis, compared to lower-potency products, was associated with an increased risk of both psychosis and cannabis use disorder. As concentrates and high-THC strains have become more widely available, this has become a growing concern.
What Happens in the Brain
THC, the compound in cannabis that produces a high, works by binding to receptors throughout the brain that normally respond to the body’s own naturally produced cannabinoids. These receptors sit on nerve cells and help regulate the release of other chemical signals, including those involved in mood, memory, and motivation.
With chronic, heavy use, the brain adapts. It reduces both the number and the responsiveness of these receptors as a protective measure against constant overstimulation. This downregulation is what drives tolerance: you need more cannabis to produce the same effect because your brain has fewer receptors available to respond. Research using brain imaging has confirmed this receptor loss in human cannabis smokers, particularly in cortical regions involved in decision-making and impulse control.
The good news is that this process appears to be reversible. Studies show receptor density begins recovering after a person stops using, though the timeline for full recovery varies.
Withdrawal Is Real
One of the most persistent misconceptions about cannabis is that it doesn’t cause physical dependence. It does. Cannabis withdrawal is recognized as a formal diagnosis, and it affects a significant portion of heavy, long-term users who stop abruptly.
Withdrawal typically begins within one to three days after the last use, peaks between days two and six, and most symptoms resolve within four to 14 days. The most commonly reported symptoms are anxiety (76% of those experiencing withdrawal), irritability and hostility (72%), difficulty sleeping (68%), and depressed mood (59%). Physical symptoms like decreased appetite, stomach pain, and shakiness also occur. The syndrome requires at least three of seven defined symptoms to be diagnosed.
Withdrawal isn’t life-threatening, but it’s uncomfortable enough to derail quit attempts. Many people who try to stop on their own relapse within the first week simply to relieve these symptoms.
Links to Other Mental Health Conditions
Cannabis use disorder rarely exists in isolation. National survey data show that people with the disorder are roughly two to three times more likely to have depression, anxiety disorders, or social anxiety compared to people without it. The relationship runs in both directions: pre-existing mental health conditions can drive heavier cannabis use as a form of self-medication, and chronic cannabis use can worsen or trigger psychiatric symptoms.
People with cannabis use disorder are also at elevated risk for other substance use problems and for psychotic disorders. This doesn’t mean cannabis use inevitably leads to these conditions, but the overlap is substantial enough that clinicians typically screen for co-occurring disorders when evaluating someone for cannabis use disorder.
Physical Health Effects
Long-term cannabis smoking is associated with respiratory problems including chronic bronchitis, airway inflammation, and increased airway resistance. These effects are similar to some of the damage caused by tobacco smoke, though separating the two is difficult since many cannabis users also smoke tobacco.
Cannabis also affects the cardiovascular system. It raises heart rate and blood pressure immediately after use, and some research links long-term use to an increased risk of stroke, heart attack, and irregular heart rhythms. The strength of this connection is still being studied, but it’s a consideration for anyone with existing heart conditions.
How Treatment Works
There are currently no medications approved specifically for cannabis use disorder. Treatment relies on behavioral therapies, with two approaches having the strongest evidence: cognitive behavioral therapy (CBT) and motivational enhancement therapy (MET). Both are effective at reducing how often people use cannabis and the severity of their dependence in the short term, though results for achieving complete abstinence are less consistent.
Programs that extend beyond four sessions over more than a month tend to work better than shorter interventions. Combining either CBT or MET with contingency management, a system that provides tangible rewards for meeting treatment goals like clean drug tests, reliably improves outcomes further.
The main challenge is durability. Treatment gains from CBT and MET typically fade by six to nine months after treatment ends. This pattern suggests that ongoing support or periodic booster sessions may be necessary for many people, similar to how other chronic conditions require long-term management rather than a one-time fix.